Study flags recombinant porcine sapelovirus with neuroinvasive signs

A new paper from China is pushing porcine sapelovirus into more urgent territory. In a June 25, 2026, brief report in Animals, researchers described a recombinant strain, PSV-ZJ, associated with outbreaks of diarrhea and neurologic disease in weaned piglets and presented evidence that the virus reached brain tissue after infection. The authors say that would make it the first reported porcine sapelovirus strain able to breach the blood–brain barrier. (mdpi.com)

That stands out because porcine sapelovirus has generally been viewed as an endemic swine picornavirus with variable clinical importance. ICTV places sapeloviruses within the family Picornaviridae, and prior literature has tied porcine sapelovirus to enteritis, respiratory disease, reproductive disorders, and occasional neurologic syndromes. Chinese surveillance studies have also shown high prevalence, substantial genetic diversity, and frequent recombination, which gives the virus room to evolve into strains with different tissue tropism or virulence. (cms.ictv.global)

According to the new report, Chinese farms have seen outbreaks since 2023 in which diarrhea appeared alongside neurologic signs such as ataxia and lameness. The authors highlighted a 2025 outbreak in Zhejiang province in weaned piglets, reporting 100% morbidity and 20% mortality among affected animals. Routine testing reportedly ruled out common swine pathogens, while qPCR was positive for porcine sapelovirus. The team isolated three strains, designated ZJ, FJ, and SD, and genetic analysis indicated that PSV-ZJ was a recombinant derived from a Chinese strain from 2011 and a Vietnamese strain from 2018. In experimental work, the researchers reported severe diarrhea, growth retardation, and marked shedding from both respiratory and digestive tracts, with qPCR and histopathology supporting viral presence in intestinal and brain tissues. (mdpi.com)

The recombination angle is important, even beyond this single outbreak. Earlier reviews and field studies have already identified recombination hotspots in porcine sapelovirus and documented broad circulation in Chinese herds. A 2023 Fujian study, for example, described high prevalence, genetic diversity, and recombination among farm strains, while other Chinese reports have characterized regional circulation in Jiangxi, Henan, Yunnan, and elsewhere. In other words, the new paper fits into an existing pattern of active viral evolution, but adds a more concerning clinical signal: apparent neuroinvasion after an outbreak that combined enteric and neurologic disease. (pmc.ncbi.nlm.nih.gov)

Independent expert reaction specific to this paper was limited at the time of writing, but the broader swine health literature supports caution. Merck Veterinary Manual lists Sapelovirus A among viral differentials for neurologic disease in pigs, and historical field reports have described outbreaks with progressive ataxia, paraparesis, and polioencephalomyelitis-like lesions. One UK case summary noted that porcine sapelovirus neurologic disease could resemble streptococcal meningitis clinically and would not be expected to respond to antimicrobials. That doesn’t validate every claim in the new paper, but it does support the practical point that PSV can be overlooked when neurologic signs dominate a case. (merckvetmanual.com)

Why it matters: For veterinary professionals, this is less about a single dramatic headline and more about case definition, diagnostics, and herd-level interpretation. If the findings hold up, veterinarians may need to think of porcine sapelovirus not only as an enteric background virus, but as a possible contributor to mixed enteric-neurologic outbreaks in weaned pigs. That could affect sample selection, including paired intestinal and CNS tissues when available, and could shape how practitioners interpret negative results for more familiar neurologic pathogens. It also reinforces the value of molecular surveillance in swine systems where recombination among RNA viruses is common. (mdpi.com)

There are still reasons to be careful. The paper is a brief report, not a large multicenter surveillance study, and the strongest claim, blood–brain barrier breaching, will likely need replication by other groups and fuller mechanistic work. The report also comes from a setting where multiple endemic pathogens can complicate interpretation, even when routine diagnostics are negative. So the immediate takeaway isn't that PSV has suddenly become a top-tier global swine threat, but that one recombinant strain may have expanded the known clinical range of the virus. (mdpi.com)

What to watch: The next signals will be whether other groups detect similar recombinant strains, whether national or regional surveillance papers link PSV more clearly with neurologic outbreaks, and whether diagnostic labs begin updating guidance or panels to account for a potentially more neurotropic sapelovirus phenotype. (mdpi.com)